Mouse study could provide foundation for future human therapeutics
Supplementing a single protein found in the spinal cord could help prevent symptoms of Lou Gehrig’s disease, according to a new study out of Case Western Reserve University School of Medicine. Researchers found high levels of the protein—called mitofusion 2 or Mfn2—prevented nerve degeneration, muscle atrophy, and paralysis in a mouse model of the disease. Since Mfn2 is often depleted during Lou Gehrig’s, the new study suggests supplementing it could be a novel therapeutic approach for the disease.
Lou Gehrig’s disease, or amyloid lateral sclerosis (ALS), is a progressive disorder that devastates motor nerve cells. People with ALS slowly lose the ability to control muscle movement, and are ultimately unable to speak, eat, move, or breathe. The cellular mechanisms behind ALS are also found in certain types of dementia. For the estimated 15,000 Americans living with ALS, the findings offer new hope for ways to delay symptoms.
“We found a way to alleviate age and ALS-related muscular atrophy in our mouse models,” said Xinglong Wang, PhD, associate professor of pathology at Case Western Reserve University School of Medicine. “Amazingly, we could delay ALS symptom onset by 67 days.”
Wang led the study, recently published in Cell Metabolism, in which researchers successfully staved off muscle atrophy and paralysis simply by increasing Mfn2 levels in mouse spinal cords.
Wang and colleagues tested the most widely used ALS mouse model. They genetically engineered the diseased mice to have increased Mfn2 levels—but only in nerve cells that extend from the spinal cord and connect to muscle fibers. In late stages of the disease, mice with high Mfn2 levels in these nerves were a healthy weight, and did not have any of the muscle atrophy, gait abnormalities, or reduced grip strength that mice in control groups developed. Even mice who underwent heavy sciatic nerve damage benefited from elevated Mfn2 levels.
Said Wang, “Upregulation of Mfn2 specifically in nerve cells is sufficient to abolish skeletal muscle loss in ALS and aged mice, despite ALS-causing protein being found in all organs and tissues.”
By studying nerve cells collected from the mice, Wang’s team uncovered how Mfn2 offers its protective effects. The researchers found Mfn2 coexists with nutrients in cell structures called mitochondria. Their experiments showed mitochondria travel along nerve cell extensions—axons—and deliver the nutrients to the point where nerve cells and muscle fibers meet. This preserves sensitive connections—synapses—between nerve and muscle cells and prevents muscle atrophy. “We found mitochondria function as miniature ‘trucks’ to transport protein along axons to prevent synaptic degeneration,” explained Wang.
Cellular transport is not typically in the job description for mitochondria. The ancient cellular structures are well-known to be “powerhouses of the cell”—producing energy that keeps cells running. According to Wang, “this is a novel, previously unrecognized role for mitochondria.”
Specifically, Wang’s team found mitochondria use Mfn2 on their surfaces to carry a nutrient called calpstatin. Calpstatin inhibits harmful enzymes that break down nerves and muscle fibers. With the help of Mfn2, mitochondria carry calpstatin along nerve cells axons to meet muscle cells. There, calpstatin prevents enzymes from destroying delicate synapse connections. But without Mfn2, mitochondria can’t carry the nutrient.
According to Wang, the findings have broad implications. “Mfn2 deficiency or mutations are commonly observed in patients with ALS, peripheral neuropathy, Alzheimer’s disease, and other neurodegenerative diseases in which synaptic loss has long been recognized as a prominent early feature,” he says. “Supplementing Mfn2 may be a common and effective therapeutic approach to treat a wide range of diseases including but not limited muscular disorders, patients with nerve injury and various major neurodegenerative diseases associated with synaptic loss.”
The Latest on: Lou Gehrig’s Disease
via Google News
The Latest on: Lou Gehrig’s Disease
- WALSH, WILLIAM R., III (Bill/Coach)on November 18, 2019 at 8:00 pm
III (Bill/Coach), - 52, of Galloway, passed away peacefully on November 15, 2019, at his home in Galloway, NJ, surrounded by loved ones. Bill fought ALS, Lou Gehrig's disease valiantly for almost 3 ...
- Former Holy Spirit football coach Bill Walsh dies after long battle with ALSon November 15, 2019 at 1:39 pm
A 1985 graduate and head football coach from 2003-2007, Walsh died after battling Lou Gehrig's disease - amyotrophic lateral sclerosis, known more as ALS. He was diagnosed in early 2016. "The ...
- Genius Fund Looking To Improve ALS Treatments, Holding First Event At Franklin Instituteon November 13, 2019 at 3:35 pm
PHILADELPHIA (CBS) — There’s new help in the fight against ALS. A Genius Fund, started here in Philadelphia, is aimed at research looking for better treatments for the disease also known as Lou Gehrig ...
- ALS walkers support fight against Lou Gehrig's diseaseon November 13, 2019 at 11:00 am
The Louisiana-Mississippi chapter of the ALS Association held a Walk to Defeat ALS on Nov. 2 at the Pennington Biomedical Research Center in Baton Rouge. ALS, or amyotrophic lateral sclerosis, is also ...
- Doctor with terminal motor neurone disease completes his transition into 'world's first cyborg'on November 13, 2019 at 4:12 am
As well as being known as ALS and Charcot's disease, MND is frequently referred to as Lou Gehrig's disease. Lou Gehrig was a hugely popular baseball player, who played for the New York Yankees between ...
- 'ALS is a monster': Two men with debilitating Lou Gehrig's disease use prayer to cope with diagnosison November 12, 2019 at 2:56 pm
AND HOW THEY JUST MIGHT LEAD TO THAT CURE. REPORTING IN DURHA Two men who are suffering the debilitating symptoms of ALS are praying for a cure. Commonly known as Lou Gehrig's disease, amyotrophic ...
- Column: The hard lessons of losson November 12, 2019 at 1:00 am
Over the course of a year, he had experienced a progressive weakness and shortness of breath. He lost a lot of weight. There was no diagnosis until Aug. 28, when we learned that he had ALS, Lou Gehrig ...
- Ex-NFL star Eric Stevens vs. ALS: ‘Our battle right now is fighting for my life’on November 11, 2019 at 3:00 pm
But he has hope. Eric Stevens is a firefighter and former Cal football player who has recently been diagnosed with ALS, the rare neurodegenerative disease that affects nerve cells in the brain and the ...
- What To Know About Medicare Insurance Plans For Newly Retired Seniorson November 11, 2019 at 8:54 am
It primarily covers people who are aged 65 or older. Nonetheless, younger adults with disabilities and those with End-Stage Renal Disease as well as amyotrophic lateral sclerosis (ALS), which is also ...
via Bing News